You are here

  • Home
  • Archive
  • Volume 13, Issue e2
  • One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

Article metrics

Article menu
Original research
One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study

 

Online download statistics by month:

Online download statistics by month: March 2021 to March 2025

AbstractFullPdf
Mar 2021450406157
Apr 202124224177
May 202145445496
Jun 202124924878
Jul 202112712555
Aug 2021807820
Sep 202111511527
Oct 2021908956
Nov 2021858649
Dec 202111311332
Jan 202212412524
Feb 2022848122
Mar 2022989721
Apr 2022959439
May 2022828427
Jun 2022747331
Jul 2022666513
Aug 2022878816
Sep 2022878623
Oct 2022535414
Nov 2022525220
Dec 2022514810
Jan 2023565418
Feb 2023575819
Mar 2023474611
Apr 202343438
May 2023393915
Jun 2023949510
Jul 202310110214
Aug 2023737211
Sep 2023697012
Oct 202313213215
Nov 2023777811
Dec 202313913043
Jan 202412511852
Feb 2024989528
Mar 2024787956
Apr 2024848434
May 2024626132
Jun 2024535122
Jul 2024676628
Aug 2024534514
Sep 2024545638
Oct 2024565232
Nov 2024403631
Dec 2024434217
Jan 2025535229
Feb 2025474628
Mar 2025474629
Total484547501564